Recruiting Breast Cancer Studies in Longmont
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
This is an umbrella study evaluating the efficacy and safety of multiple treatment combinations in participants with metastatic or inoperable locally advanced breast cancer. The study will be perform...
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs....
About Breast Cancer Clinical Trials in Longmont
Breast cancer is a disease in which cells in the breast grow out of control. It is the most common cancer in women worldwide and can also occur in men. Treatment options include surgery, radiation, chemotherapy, hormone therapy, and targeted therapies.
There are currently 2 breast cancer clinical trials recruiting participants in Longmont, COLORADO. These studies are seeking a combined 704 participants. Research is being sponsored by Hoffmann-La Roche, RayzeBio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Breast Cancer Clinical Trials in Longmont — FAQ
Are there breast cancer clinical trials in Longmont?
Yes, there are 2 breast cancer clinical trials currently recruiting in Longmont, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Longmont?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Longmont research site will contact you about next steps.
Are clinical trials in Longmont free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Longmont studies also compensate for your time and travel.
What breast cancer treatments are being tested?
The 2 active trials in Longmont are testing new therapies including novel drugs, biologics, and treatment approaches for breast cancer.
Data updated March 2, 2026 from ClinicalTrials.gov